PH12019500934A1 - Opthalmic solution comprising epinastine - Google Patents

Opthalmic solution comprising epinastine

Info

Publication number
PH12019500934A1
PH12019500934A1 PH12019500934A PH12019500934A PH12019500934A1 PH 12019500934 A1 PH12019500934 A1 PH 12019500934A1 PH 12019500934 A PH12019500934 A PH 12019500934A PH 12019500934 A PH12019500934 A PH 12019500934A PH 12019500934 A1 PH12019500934 A1 PH 12019500934A1
Authority
PH
Philippines
Prior art keywords
epinastine
opthalmic solution
eye drops
antiseptic
opthalmic
Prior art date
Application number
PH12019500934A
Other languages
English (en)
Inventor
Masahiro Kawahata
Naoki Matsumoto
Hiroyuki Inoue
Tomoki Hara
Sachie Hikage
Takashi Morimoto
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of PH12019500934A1 publication Critical patent/PH12019500934A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH12019500934A 2016-10-28 2019-04-25 Opthalmic solution comprising epinastine PH12019500934A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016211535A JP6134853B1 (ja) 2016-10-28 2016-10-28 エピナスチン含有点眼液
PCT/JP2017/038948 WO2018079721A1 (ja) 2016-10-28 2017-10-27 エピナスチン含有点眼液

Publications (1)

Publication Number Publication Date
PH12019500934A1 true PH12019500934A1 (en) 2019-12-02

Family

ID=58745757

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12019500934A PH12019500934A1 (en) 2016-10-28 2019-04-25 Opthalmic solution comprising epinastine

Country Status (7)

Country Link
JP (1) JP6134853B1 (ko)
KR (3) KR102659499B1 (ko)
AU (1) AU2017348597A1 (ko)
MY (1) MY192577A (ko)
PH (1) PH12019500934A1 (ko)
TW (1) TWI750248B (ko)
WO (1) WO2018079721A1 (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018203424A1 (ja) * 2017-05-01 2018-11-08 参天製薬株式会社 点眼剤
JP7355539B2 (ja) * 2018-07-20 2023-10-03 ロート製薬株式会社 眼科組成物
JP7458159B2 (ja) * 2018-09-28 2024-03-29 ロート製薬株式会社 眼科組成物
JP2019108320A (ja) * 2018-10-31 2019-07-04 参天製薬株式会社 ソフトコンタクトレンズの変質を抑制する眼科用組成物
JP6736752B2 (ja) * 2019-12-17 2020-08-05 参天製薬株式会社 エピナスチン含有点眼液
JP2020169213A (ja) * 2020-07-15 2020-10-15 参天製薬株式会社 エピナスチン含有点眼液

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
KR20110104367A (ko) * 2010-03-16 2011-09-22 삼천당제약주식회사 무보존제 안과용 조성물
EP2664329A1 (de) * 2012-05-15 2013-11-20 F. Holzer GmbH Ophthalmologisches Vehikelsystem
JPWO2015125921A1 (ja) * 2014-02-20 2017-03-30 わかもと製薬株式会社 保存効力を有する医薬用水性組成物

Also Published As

Publication number Publication date
JP2018070500A (ja) 2018-05-10
TW201821060A (zh) 2018-06-16
WO2018079721A1 (ja) 2018-05-03
TWI750248B (zh) 2021-12-21
KR20190075956A (ko) 2019-07-01
MY192577A (en) 2022-08-29
KR20230014870A (ko) 2023-01-30
AU2017348597A1 (en) 2019-05-16
KR20240054409A (ko) 2024-04-25
KR102659499B1 (ko) 2024-04-19
JP6134853B1 (ja) 2017-05-24
KR102491425B1 (ko) 2023-01-20

Similar Documents

Publication Publication Date Title
PH12019500934A1 (en) Opthalmic solution comprising epinastine
PH12017500837A1 (en) Container containing a nicotine solution
EA201890269A1 (ru) Гербицидная композиция, содержащая цинметилин и напропамид
EA201890265A1 (ru) Гербицидная композиция, содержащая цинметилин и метазахлор
EA201890263A1 (ru) Гербицидная композиция, содержащая цинметилин и метолахлор или s-метолахлор
CL2016002815A1 (es) Solución oftálmica acuosa y método para tratar el síndrome del ojo seco
EA201791467A1 (ru) Водный офтальмологический раствор
MX366262B (es) Composicion que contiene peroxido y agente antimicrobiano y proceso de matar esporas.
PH12018500887A1 (en) Anti-htra1 antibodies and methods of use thereof
MX2018003554A (es) Benzamidas sustituidas con isoxazolina y analogos como insecticidas.
MX2016013155A (es) Proceso para matar esporas con el uso de una composicion de peroxido en vapor.
NZ746468A (en) Methods of treating ocular conditions
PH12017501567A1 (en) Ophthalmic composition
WO2018189661A3 (en) Methods and compounds for treating diabetes
WO2015130547A8 (en) Bis-cyclic guanidine compound compositions, methods of use and treatment thereof
PH12016502386B1 (en) Oral care compositions
MX2019008338A (es) Composicion farmaceutica que contiene sulglicotido o una sal farmaceuticamente aceptable del mismo para la prevencion o tratamiento del ojo seco.
MX2020005242A (es) Composiciones agroquimicas.
PL3799567T3 (pl) Krople do oczu zawierające kwas cytrynowy jako jedyny aktywny składnik
WO2015108999A8 (en) Bioactive heme-haloperoxidase compositions and methods of their use
PH12019502145A1 (en) Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising tiotropium as active ingredient
GB201208080D0 (en) Tobramycin formulation
WO2017066562A3 (en) Artificial metalloenzymes containing noble metal-porphyrins
MX2016015366A (es) Una composicion de toxicidad baja.
EA202190114A1 (ru) Способы лечения clrn1-ассоциированной потери слуха и/или потери зрения